The Putative Mechanism of Lymphopenia in COVID-19 Patients

Xinling Wang,Zezhong Liu,Lu,Shibo Jiang
DOI: https://doi.org/10.1093/jmcb/mjac034
2022-01-01
Journal of Molecular Cell Biology
Abstract:Severe acute respiratory syndrome coro-navirus 2(SARS-CoV-2)and its vari-ants have caused>500 million con-firmed cases and>6 million deaths.Apart from the common clinical manifes-tations,63%of admitted coronavirus dis-ease 2019(COVID-19)patients had lym-phopenia,increasing to 85%in patients with severe disease(Huang et al.,2020).It has been reported that several genes representing the p53-mediated apopto-sis signaling pathway are upregulated in peripheral blood mononuclear cells(PBMCs)of COVID-19 patients(Xiong etal.,2020).Moreover,SARS-CoV-2 RNA is detected in most immune cells,includ-ing T and B lymphocytes and NK cells(Ren et al.,2021).Therefore,unravel-ing the mechanism of lymphopenia in COVID-19 patients depends on whether SARS-CoV-2 directly infects immune cells to induce cell death.
What problem does this paper attempt to address?